PeptideStack
5.2kquestions
20kanswers
220users

Is survodutide at 8 mg/mL stable enough for ten weeks of multi-withdrawal use?

Asked 17 Mar 2025Modified 13 months agoViewed 21k times
33

The case in front of me: survodutide · 8 mg/mL · ten weeks.

The claim is plausible, which is exactly why I want to check it.

I am able to read a paper if someone points me at one.

Can anyone point me at a primary source, or confirm that there is not one?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
bacteriostatic-water
bacteriostatic-water

Water for injection containing roughly 0.9 per cent benzyl alcohol as a bacteriostatic agent. It suppresses growth in a multiple-withdrawal vial;…

149 questions
shelf-life
shelf-life

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and…

327 questions
survodutide
survodutide

A GLP-1 and glucagon receptor dual agonist with a substantial published MASH dataset. Use this tag for its hepatic endpoints, its dose ladder, and…

225 questions
shareeditfollowflag
IP
askedivo_paunovic16k2717 Mar 2025
3Same question here after a warm delivery, so I am following this. – nine_point_nine 6 months ago
2Worth saying whether the vial has been opened, because that starts a different clock. – ayo_fadipe 4 months ago
add a comment

2 Answers

Sorted by votes
51

ten weeks is 70 days and, on a weekly schedule, 10 stopper punctures out of one vial at 8 mg/mL. Set the chemical question aside for a moment, because the puncture count is the one with a convention attached: 70 days is 2.5 times the twenty-eight days conventionally allowed for a preserved multi-dose preparation once it has been entered. Chemically, 8 mg/mL is high enough that adsorption to the glass is a rounding error and low enough that it is not protecting you from anything. What 10 withdrawals do add is 10 opportunities to introduce air, 10 coring events on the same stopper, and a headspace that grows with every draw — none of which show up on a certificate and all of which are avoided by splitting into aliquots at reconstitution.

The relevant point is that a mass shift of plus one dalton is deamidation and plus sixteen is oxidation, so degradation is often visible in a mass spectrum if anyone looks.

Oxidation targets methionine, cysteine and tryptophan, adding sixteen daltons per oxygen. It is catalysed by trace metals and promoted by dissolved oxygen and by light.

A mass spectrum resolves most of this: minus eighteen is dehydration or succinimide, plus one is deamidation, plus sixteen is oxidation, and an unchanged mass with a shifted retention time is an isomer.

Metal-catalysed oxidation of methionine is documented across peptide and protein formulations and is why chelators appear in some formulations.

Sequence determines which pathways apply, so general statements are general.

Swirl, never shake. Aggregation is a handling problem more than a time problem.

edited 15 Jul 2025 by e_dziedzic — added the method parameters

shareimprove this answerflag
ED
answerede_dziedzic51k14722 Jun 2025
4Does the same reasoning apply to material already in solution, or is that a different curve? – Dr_Ilse_Vandenberg 4 months ago
3The desiccant point is under-appreciated and costs nothing to act on. – amara_nwachukwu 3 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
17

Asparagine and glutamine are the deamidation risk, and methionine is the oxidation risk.

Hydrolysis cleaves the backbone, most readily at aspartate-proline and aspartate-glycine sequences, and is acid-catalysed. In a dry solid it barely proceeds at all.

More usefully, freeze-thaw cycling drives aggregation through concentration at the ice interface and pH shifts as buffer components crystallise out at different rates. Each cycle costs something.

Adsorption losses at low concentrations are quantified in formulation studies and are the reason carrier proteins are used in dilute preparations.

Apparent loss in a dilute preparation is usually adsorption rather than degradation and is worth ruling out first.

Sequence decides which pathways are even available. Check the residues.

shareimprove this answerflag
MH
answeredm_haraldsen21k273 Jul 2025
5Worth adding that residual moisture predicts this better than any printed date. – Dr_Signe_Baldursdottir 5 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.